SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Mankind Pharma

BSE: 543904 29 Jun 2025
Healthcare
₹ 2298.05
Mankind Pharma Limited specializes in Pharmaceuticals within the Healthcare sector.

Mankind Pharma - Share Price & Details

Market Cap
₹96,306
High /Low
3,055 / 1,901
Stock P/E
48.5
Book Value
₹347.0
Dividend Yield
0.0
ROCE
17.9
ROE
₹16.8
Face Value
1.0
PEG Ratio
3.29
EVEBITDA
₹29.2
Debt
8,511
CMP / FCF
62.1
Debt to equity
₹0.59
NP Ann
2,011
High price all time
3,055
Piotroski score
₹4.0
Graham Number
614.0
No. Eq. Shares
41.3
Net CF
₹-37.0
Net profit
2,011
Price to book value
6.72
Interest Coverage
₹6.86
Low price all time
1,241
Industry PE
32.7
Reserves
₹14,291
Free Cash Flow
₹1,895

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
Mankind Pharma Limited23459.13824.621265.99.2596,30648.5
LUPIN LTD.45344.612913.544856.728.218838026.9
ABBOTT INDIA LTD.NANANANA7424852.5

Peer Comparison Chart


About Mankind Pharma

Mankind Pharma Limited, with Security Code 543904, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Mankind Pharma Sees Significant Open Interest Surge Amid Increased Derivatives Activity

(12 Jun 2025)
Mankind Pharma Ltd has seen a notable rise in open interest, reaching 5,571 contracts, alongside a trading volume of 9,450 contracts,...
Read more →

Mankind Pharma Shares Rise 2.24% in Today's Trading Amid Very Bearish Sentiment

(12 Jun 2025)
Mankind Pharma's stock currently trades at Rs 2432.00, reflecting a positive movement despite the prevailing bearish sentiment in the...
Read more →

Mankind Pharma Passing through a Rough Patch

(11 Jun 2025)
Mankind Pharma Limited (Mankind), established in 1995, is a fast-growing pharmaceuticals and consumer healthcare company. It has implemented a unique...
Read more →

Mankind Pharma allots 57,709 equity shares under ESOP

(10 Jun 2025)
Mankind Pharma has allotted 57,709 equity shares of face value of Re. 1/- each of the Company to the eligible employees who have exercised...
Read more →

Mankind to expand gastro, derma presence, says MD Rajeev Juneja | Company Business News

(28 May 2025)
The pharmaceutical company is evaluating all options to increase its presence in therapy areas, including in-licensing products from...
Read more →

The Mankind Pharma Limited (NSE:MANKIND) Full-Year Results Are Out And Analysts Have Published New Forecasts

(24 May 2025)
Last week, you might have seen that Mankind Pharma Limited ( NSE:MANKIND ) released its full-year result to the market...
Read more →